Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver

Biochemical and Biophysical Research Communications

Volumn 262, Issue 2, 1999, Pages 499-503

  Sumida, Akihiko ^a   Kinoshita, Kayoko ^a   Fukuda, Tsuyoshi ^a   Matsuda, Hideyasu ^a   Yamamoto, Isamu ^a   Inaba, Tadanobu ^b   Azuma, Junichi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

CYP2E1; CYP3A4; Human liver; Metabolic activity; mRNA; Reverse transcription competitive PCR

Indexed keywords

BETA ACTIN; CYTOCHROME P450; CYTOCHROME P450 3A4; DIMETHYLNITROSAMINE DEMETHYLASE; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; HYDROXYLATION; LIVER METABOLISM; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EUKARYOTA;

EID: 0033610010     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1999.1233     Document Type: Article

References (13)

1. Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich F. P. J. Pharmacol. Exp. Ther. 270:1994;414-423.
2. Bertz R. J., Granneman G. R. Clin. Pharmacokinet. 32:1997;210-258.
3. Ingelman-Sundberg M., Johansson I. J. Biol. Chem. 259:1984;6447-6458.
4. Kim H., Reddy S., Novak R. F. Drug Metab. Dispos. 23:1995;818-824.
5. Sumida A., Yamamoto I., Zhou Q., Morisaki T., Azuma J. Biol. Pharm. Bull. 22:1999;61-65.
6. Andersen M. R., Farin F. M., Omiecinski C. J. DNA Cell Biol. 17:1998;231-238.
7. Inaba T., Fischer N. E., Riddick D. S., Stewart D. J., Hidaka T. Toxicol. Lett. 93:1997;215-219.
8. Bork R. W., Muto T., Beaune P. H., Srivastava P. K., Lloyd R. S., Guengerich F. P. J. Biol. Chem. 264:1989;910-919.
9. Guengerich F. P., Turvy C. G. J. Pharmacol. Exp. Ther. 256:1991;1189-1194.
10. Rebbeck T. R., Jaffe J. M., Walker A. H., Wein A. J., Malkowicz S. B. J. Natl. Cancer Inst. 90:1998;1225-1229.
11. Westlind A., Löfberg L., Tindberg N., Andersson T. B., Ingelman-Sundberg M. Biochem. Biophys. Res. Commun. 259:1999;201-205.
12. Powell H., Kitteringham N. R., Pirmohamed M., Smith D. A., Park B. K. Pharmacogenetics. 8:1998;411-421.
13. Ronis M. J. J., Lindros K. O., Ingelman-Sundberg M. The CYP2E Subfamily. Ioannides C. Cytochromes P450. Metabolic and Toxicological Aspects. 1996;211-239 CRC Press, Boca Raton.